Back to Search
Start Over
The Incidence and Associated Factors of Early Neurological Deterioration After Thrombolysis: Results From SITS Registry.
- Source :
-
Stroke [Stroke] 2020 Sep; Vol. 51 (9), pp. 2705-2714. Date of Electronic Publication: 2020 Aug 19. - Publication Year :
- 2020
-
Abstract
- Background and Purpose: Early neurological deterioration (END) after stroke onset may predict severe outcomes. Estimated rates of END after intravenous thrombolysis among small patient samples have been reported up to 29.8%. We studied the incidence and factors associated with END among patients following intravenous thrombolysis.<br />Methods: We analyzed SITS-International Stroke Thrombolysis registry patients with known outcomes enrolled in 2010 to 2017. END was defined as an increase in National Institutes of Health Stroke Scale score ≥4 or death within 24 hours from baseline National Institutes of Health Stroke Scale. We determined the incidence of END and used logistic regression models to inspect its associated factors. We adjusted for variables found significant in univariate analyses ( P <0.05). Main outcomes were incidence of END, associated predictors of END, ordinal day-90 mRS, and day-90 mortality.<br />Results: We excluded 53 539 patients and included 50 726 patients. The incidence of END was 3415/50 726 (6.7% [95% CI, 6.5%-7.0%]). Factors independently associated with END on multivariate analysis were intracerebral hemorrhage (OR, 3.23 [95% CI, 2.96-3.54], P <0.001), large vessel disease (LVD) with carotid stenosis (OR, 2.97 [95% CI, 2.45-3.61], P <0.001), other LVD (OR, 2.41 [95% CI, 2.03-2.88], P <0.001), and ischemic stroke versus transient ischemic attack (TIA)/stroke mimics (OR, 16.14 [95% CI, 3.99-65.3], P <0.001). END was associated with worse outcome on ordinal mRS: adjusted OR 2.48 (95% CI, 2.39-2.57, P <0.001) by day-90 compared with no END. The adjusted OR for day-90 mortality was 9.70 (95% CI, 8.36-11.26, P <0.001).<br />Conclusions: The routinely observed rate of END reflected by real-world data is low, but END greatly increases risk of disability and mortality. Readily identifiable factors predict END and may help with understanding causal mechanisms to assist prevention of END.
- Subjects :
- Aged
Aged, 80 and over
Brain Ischemia complications
Brain Ischemia therapy
Disability Evaluation
Female
Fibrinolytic Agents therapeutic use
Humans
Incidence
Ischemic Attack, Transient complications
Ischemic Attack, Transient therapy
Male
Middle Aged
Nervous System Diseases epidemiology
Nervous System Diseases mortality
Predictive Value of Tests
Registries
Retrospective Studies
Risk Factors
Stroke mortality
Tissue Plasminogen Activator therapeutic use
Treatment Outcome
Nervous System Diseases etiology
Stroke complications
Stroke therapy
Thrombolytic Therapy methods
Subjects
Details
- Language :
- English
- ISSN :
- 1524-4628
- Volume :
- 51
- Issue :
- 9
- Database :
- MEDLINE
- Journal :
- Stroke
- Publication Type :
- Academic Journal
- Accession number :
- 32811373
- Full Text :
- https://doi.org/10.1161/STROKEAHA.119.028287